Is Novavax A Buy Right Now? A Look At The Stock And Its Coronavirus Vaccine Candidate

Over the course of the past 12 months, Novavax has gone from penny stock status before the pandemic to skyrocketing more than 2,700% over the course of the pandemic thus far. So is Novavax, which today’s article notes is “battl[ing] against big pharma and biotech companies for a coronavirus vaccine”, a buy right now? To answer this question, the author offers a fundamental and technical analysis of the stock, as well as a look at the stock’s history and its coronavirus vaccine candidate. For more, CLICK HERE.